PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2127952
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2127952
The global anti-snoring devices market was valued at USD 1.06 billion in 2025 and is projected to grow from USD 1.14 billion in 2026 to USD 2.00 billion by 2032, registering a CAGR of 7.36% during the forecast period. North America dominated the global market with a 37.88% market share in 2025, supported by the high prevalence of sleep disorders, increasing awareness of obstructive sleep apnea (OSA), and the widespread availability of advanced anti-snoring products.
Anti-snoring devices are non-invasive solutions designed to keep the airway open during sleep by preventing airway obstruction and reducing tissue vibration. Popular products include mandibular advancement devices (MADs), tongue retaining devices (TRDs), nasal dilators, chin straps, and CPAP accessories. These products are increasingly being adopted by individuals suffering from habitual snoring and mild to moderate obstructive sleep apnea. Rising consumer preference for affordable, non-surgical treatment options and the growing availability of over-the-counter (OTC) devices continue to support market expansion worldwide.
Market Drivers
The rising prevalence of sleep disorders is one of the strongest factors driving the anti-snoring devices market. According to recent global estimates, nearly 936 million adults aged 30-69 years suffer from mild to severe obstructive sleep apnea, creating significant demand for effective treatment options. Untreated snoring and sleep apnea are associated with cardiovascular diseases, daytime fatigue, poor concentration, and reduced quality of life, encouraging patients to seek convenient therapeutic solutions.
Anti-snoring devices provide a comfortable and cost-effective alternative to surgical interventions and continuous positive airway pressure (CPAP) therapy, especially for patients with mild to moderate conditions. Increasing public awareness regarding sleep health, coupled with growing healthcare expenditure, continues to strengthen product demand across developed and emerging economies.
Market Trends
A key trend transforming the industry is the growing adoption of smart, non-invasive anti-snoring devices integrated with digital technologies. Manufacturers are incorporating Bluetooth connectivity, AI-enabled monitoring, sensors, and mobile applications that track sleep quality and personalize treatment settings.
Innovative product launches are further accelerating adoption. For example, FDA-cleared devices equipped with compliance monitoring technology are enabling healthcare providers to remotely monitor patient usage and improve treatment outcomes. The integration of telemedicine with sleep disorder management is also creating new opportunities for manufacturers to reach a wider patient base.
Market Restraints
Despite favorable growth prospects, limited consumer awareness remains a significant challenge, particularly across developing countries. Many individuals consider snoring a harmless condition and therefore avoid seeking medical treatment. In addition, concerns regarding device comfort, effectiveness, and long-term compliance continue to limit adoption among some users.
Competition from CPAP therapy and surgical procedures also restricts market growth. Since CPAP remains the preferred treatment for moderate to severe obstructive sleep apnea and is often covered by insurance, healthcare providers frequently recommend it over OTC anti-snoring devices.
Market Segmentation
By Device Type
The mandibular advancement devices (MADs) segment is expected to dominate the global market with a 42.23% market share in 2026. These devices remain the preferred treatment option for patients with habitual snoring and mild to moderate obstructive sleep apnea due to their clinical effectiveness, comfort, and ease of use. Manufacturers continue investing in product innovation and partnerships with dental clinics to increase adoption.
The tongue retaining devices, nasal devices, CPAP machines & accessories, and other anti-snoring products are also witnessing steady demand as patients seek personalized treatment options.
By Distribution Channel
The retail pharmacies segment is projected to lead the market with a 38.90% share in 2026, supported by increasing retail pharmacy networks and improved product accessibility. Strategic supply agreements between manufacturers and pharmacy chains are further strengthening sales through offline channels.
Meanwhile, the online pharmacies segment is expected to register the fastest growth throughout the forecast period due to increasing consumer preference for e-commerce, teleconsultation, and home delivery services.
North America generated USD 0.40 billion in 2025 and is expected to reach USD 0.43 billion in 2026, maintaining its leading position in the global market. The U.S. alone is projected to account for USD 0.41 billion in 2026, driven by the high prevalence of sleep apnea, greater awareness, favorable reimbursement policies, and advanced healthcare infrastructure.
Europe accounted for USD 0.30 billion in 2025 and is anticipated to reach USD 0.32 billion in 2026, supported by an established healthcare system, strong distribution networks, and the presence of major market participants.
Asia Pacific reached USD 0.26 billion in 2025 and is forecast to grow to USD 0.28 billion in 2026, driven by increasing diagnosis of sleep disorders, expanding healthcare access, and rising disposable income across China, India, and other emerging countries.
Latin America generated USD 0.06 billion in 2025 and is expected to reach USD 0.07 billion in 2026, while the Middle East & Africa market stood at USD 0.04 billion in 2025 and is projected to maintain gradual growth through the forecast period.
Competitive Landscape
The global anti-snoring devices market is moderately consolidated, with leading companies focusing on product innovation, geographic expansion, strategic collaborations, and awareness campaigns to strengthen their market position.
Major companies operating in the market include ResMed, Fisher & Paykel Healthcare Limited, SomnoMed, Glidewell, ProSomnus Sleep Technologies, PANTHERA DENTAL, BlueSleep, Apnea Sciences, Frantz Design Inc., and DynaFlex.
Recent industry developments include product launches, FDA approvals, supplier partnerships, and reimbursement-focused initiatives aimed at improving patient access and expanding commercial reach.
Conclusion
The global anti-snoring devices market is expected to witness steady growth through the forecast period, increasing from USD 1.06 billion in 2025 to USD 1.14 billion in 2026, ultimately reaching USD 2.00 billion by 2032. Rising awareness of sleep disorders, increasing prevalence of obstructive sleep apnea, technological advancements in smart anti-snoring devices, and expanding retail and online distribution channels are expected to sustain long-term market growth. Although competition from CPAP therapy and limited awareness in emerging regions remain challenges, continuous product innovation and expanding healthcare access are expected to create significant opportunities for manufacturers worldwide.
Segmentation By Device Type, Distribution Channel, and Region
By Device Type * Mandibular Advancement Devices
By Distribution Channel * Hospital Pharmacies
By Geography * North America (By Device Type, Distribution Channel, and Country)